<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03988075</url>
  </required_header>
  <id_info>
    <org_study_id>2018-022</org_study_id>
    <nct_id>NCT03988075</nct_id>
  </id_info>
  <brief_title>Non-opioid Based Pain Control After Thyroidectomy</brief_title>
  <official_title>Use of Enhanced Recovery After Surgery (ERAS) in Minimizing Opioid Use for Patients Undergoing Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain control modalities were evaluated after thyroidectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain control modalities were evaluated after thyroidectomy. Patients were randomized to one
      of two pain control regimens. The control group received conventional opioid based post
      operative analgesia while the test group received an enhanced recovery after surgery (ERAS)
      based anesthesia with use of acetaminophen and non-steroidal anti-inflammatory drugs for the
      post operative period with opioid medications available for break through pain only. Pain
      scores (measured on visual analog scale) and opioid use (measured in morphine equivalent
      dose) were measured after completion of the operation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 24, 2018</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized to one of two study groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analog scale pain level</measure>
    <time_frame>1 hour post operatively</time_frame>
    <description>Pain level from 0 (no pain) to 10 (worst pain imaginable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analog scale pain level</measure>
    <time_frame>6 hour post operatively</time_frame>
    <description>Pain level from 0 (no pain) to 10 (worst pain imaginable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analog scale pain level</measure>
    <time_frame>24 hour post operatively</time_frame>
    <description>Pain level from 0 (no pain) to 10 (worst pain imaginable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analog scale pain level</measure>
    <time_frame>7 days post operatively</time_frame>
    <description>Pain level from 0 (no pain) to 10 (worst pain imaginable).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>opioid use</measure>
    <time_frame>with the first 24 hours post operatively</time_frame>
    <description>the dose of opioid received by the patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Pain</condition>
  <condition>Thyroidectomy</condition>
  <arm_group>
    <arm_group_label>Acetaminophen and hydrocodone based pain control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive acetaminophen 650mg every 4 for pain level 1-3, hydrocodone/acetaminophen 5/325mg every 4 for pain level 4-6, or hydrocodone/acetaminophen 10/650mg every 4 for pain level 7-10 on as needed basis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen and ibuprofen based pain control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive standing dose of acetaminophen 650mg every 8 hours and ibuprofen 800mg every 8 hours with alternating ibuprofen and acetaminophen every 4 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acetaminophen and hydrocodone based pain control</intervention_name>
    <description>Patients receive acetaminophen 650mg every 4 for pain level 1-3, hydrocodone/acetaminophen 5/325mg every 4 for pain level 4-6, or hydrocodone/acetaminophen 10/650mg every 4 for pain level 7-10 on as needed basis.</description>
    <arm_group_label>Acetaminophen and hydrocodone based pain control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acetaminophen and ibuprofen based pain control</intervention_name>
    <description>Patients receive standing dose of acetaminophen 650mg every 8 hours and ibuprofen 800mg every 8 hours with alternating ibuprofen and acetaminophen every 4 hours.</description>
    <arm_group_label>Acetaminophen and ibuprofen based pain control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  thyroid disease

        Exclusion Criteria:

          -  currently on opioid pain medications

          -  on opioid pain meds in last 30 days

          -  cannot take non-opioid medications

          -  require more extensive operation than thyroidectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erin Felger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medstar Health Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Francis DO, Randolph G, Davies L. Nationwide Variation in Rates of Thyroidectomy Among US Medicare Beneficiaries. JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1122-1125. doi: 10.1001/jamaoto.2017.1746.</citation>
    <PMID>29049468</PMID>
  </results_reference>
  <results_reference>
    <citation>Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017 Jun 21;152(6):e170504. doi: 10.1001/jamasurg.2017.0504. Epub 2017 Jun 21. Erratum in: JAMA Surg. 2019 Mar 1;154(3):272.</citation>
    <PMID>28403427</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. Review.</citation>
    <PMID>11222424</PMID>
  </results_reference>
  <results_reference>
    <citation>Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. Review.</citation>
    <PMID>12095591</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 14, 2019</study_first_submitted>
  <study_first_submitted_qc>June 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2019</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

